SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-144267
Filing Date
2019-05-10
Accepted
2019-05-10 16:17:38
Documents
62
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d944356d10q.htm 10-Q 642690
2 EX-31.1 d944356dex311.htm EX-31.1 6438
3 EX-31.2 d944356dex312.htm EX-31.2 6389
4 EX-32.1 d944356dex321.htm EX-32.1 6301
  Complete submission text file 0001193125-19-144267.txt   5630901

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cfrx-20190331.xml EX-101.INS 1686784
6 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20190331.xsd EX-101.SCH 38909
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20190331_cal.xml EX-101.CAL 36563
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20190331_def.xml EX-101.DEF 136813
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20190331_lab.xml EX-101.LAB 334223
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20190331_pre.xml EX-101.PRE 251749
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 19815163
SIC: 2834 Pharmaceutical Preparations